ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Up 13.8% in December

ASP Isotopes Inc. (NASDAQ:ASPI) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 6,770,000 shares, an increase of 13.8% from the December 15th total of 5,950,000 shares. Based on an average daily volume of 5,090,000 shares, the days-to-cover ratio is currently 1.3 days. Currently, 14.6% of the shares of the company are sold short.

Institutional Investors Weigh In On ASP Isotopes

Large investors have recently made changes to their positions in the company. SG Americas Securities LLC acquired a new position in shares of ASP Isotopes during the fourth quarter worth approximately $100,000. JPMorgan Chase & Co. increased its holdings in shares of ASP Isotopes by 31.4% during the third quarter. JPMorgan Chase & Co. now owns 22,196 shares of the company’s stock valued at $62,000 after purchasing an additional 5,307 shares during the period. B. Riley Wealth Advisors Inc. bought a new stake in shares of ASP Isotopes during the third quarter valued at about $42,000. Sanctuary Advisors LLC acquired a new stake in ASP Isotopes in the third quarter worth about $66,000. Finally, Barclays PLC lifted its holdings in ASP Isotopes by 438.5% in the third quarter. Barclays PLC now owns 72,330 shares of the company’s stock worth $201,000 after purchasing an additional 58,897 shares during the period. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Trading Up 10.1 %

Shares of ASP Isotopes stock traded up $0.52 during trading on Friday, hitting $5.66. 2,735,525 shares of the stock were exchanged, compared to its average volume of 2,112,098. The stock’s fifty day moving average is $5.51 and its 200 day moving average is $4.08. ASP Isotopes has a 12 month low of $1.86 and a 12 month high of $9.33. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on ASPI shares. Canaccord Genuity Group started coverage on shares of ASP Isotopes in a research report on Friday, October 4th. They issued a “buy” rating and a $4.50 price target on the stock. Canaccord Genuity Group restated a “buy” rating and issued a $4.50 target price on shares of ASP Isotopes in a research note on Friday, October 18th.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.